testo-alternativo
Military Fungus Crisis: 17% Infection Rate, Global Migration, and Personalized Treatment Innovations

Advancements in Dermatology: A Weekly Review

Dermatologia e Venerologia

Military Fungus Crisis: 17% Infection Rate, Global Migration, and Personalized Treatment Innovations

From military barracks to hospital wards, fungal infections are emerging as a complex global challenge. This episode of Advancements in Dermatology examines how climate, genetics, and global mobility are fueling new patterns of infection — and how innovative diagnostics and therapies are changing the way we treat them.
Featuring extraordinary cases from around the world, this episode reveals the evolving science behind one of dermatology’s most underestimated fields.

Login or Register to listen to this episode

Bibliography

Sepahvand A et al. Prevalence of Tinea pedis in military personnel: a systematic review and meta-analysis. BMC Public Health. 2025;25(1):3116.


Guo C et al. Disseminated Blastomycosis Mimicking Tuberculosis, China. Emerg Infect Dis. 2025;31(10):2046–2048.


Xie Z et al. Imported fungal infection: first report of tinea capitis due to Microsporum audouinii in China. Emerg Microbes Infect. 2025;14(1):2556725.


Obagi S et al. Cutaneous Coccidioidomycosis Mimicking Rosacea in an Immunosuppressed Patient, Arizona, USA. Emerg Infect Dis. 2025;31(10):2038–2040.


Nguyen S et al. Saksenaea vasiformis mucormycosis following caesarean section: a case report. Int J Surg Case Rep. 2025;135:111923.


Saadeldein MS et al. Advanced eumycetoma with intracranial extension: three Sudanese cases and literature review. J Med Case Rep. 2025;19(1):451.


Xiang Y et al. Chronic mucocutaneous candidiasis with a novel STAT1 gain-of-function mutation. J Clin Immunol. 2025;45(1):137.


Kishida Y et al. Disseminated Fusariosis successfully treated with liposomal amphotericin B and voriconazole combination therapy. Intern Med. 2025;64(19):2907–2912


García-Oreja S et al. Laser and photodynamic therapy versus ciclopirox nail lacquer for onychomycosis: a randomized controlled trial. Mycoses. 2025;68(10):e70121.

Comments

Please Login to leave a comment.

No comments yet. Be the first to comment!